Study evaluates costs and benefits associated with new colon cancer therapies

New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals...

Read the whole article on

More from